Clinical Trial Update: Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Chinese Population Aged 2 Years and Above [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in healthy Chinese individuals aged 2 years a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• 23-valent pneumococcal polysaccharide vaccine (Pneumococcal polysaccharide vaccine 23-valent)

Snippet

Sponsor: Ab&B Bio-tech Co., Ltd.JS | Conditions: Pneumonia | Phase 1 | Status: COMPLETED